Compass Therapeutics (CMPX) Accumulated Depreciation (2019 - 2026)
Compass Therapeutics (CMPX) posted Accumulated Depreciation of $6.7 million for Q1 2026, little changed sequentially from $6.6 million in Q4 2025, and little changed YoY from $6.6 million in Q1 2025.
Compass Therapeutics (CMPX) Accumulated Depreciation (2019 - 2026) Analysis & Trends
Compass Therapeutics has reported Accumulated Depreciation for 8 years, with the latest figure at $6.7 million in Q1 2026.
- Quarterly Accumulated Depreciation changed 0.23% year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (changed 0.23% YoY) and the FY2025 annual result came in at $6.6 million, up 4.34% from the prior year.
- Accumulated Depreciation was little changed at $6.7 million in Q1 2026 per CMPX's latest filing, from $6.6 million in the prior quarter.
- Over five years, Accumulated Depreciation peaked at $6.7 million in Q3 2024 and troughed at $5.2 million in Q2 2022.
- A 5-year average of $6.2 million and a median of $6.4 million in 2024 frame the typical range for Accumulated Depreciation.
- The sharpest annual moves came in 2023 and 2025: Accumulated Depreciation rose 14.91% in 2023, then fell 1.43% in 2025.
- Over 5 years, Accumulated Depreciation stood at $5.6 million in 2022, then grew by 12.55% to $6.3 million in 2023, then rose by 1.5% to $6.4 million in 2024, then gained by 4.34% to $6.6 million in 2025, then gained by 0.23% to $6.7 million in 2026.
- According to Business Quant data, Accumulated Depreciation over the past three periods registered $6.7 million, $6.6 million, and $6.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Compass Therapeutics | 405.20 Mn | 405.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.59 Mn |
| Mar 31, 2026 | 6.65 Mn |
| Dec 31, 2025 | 6.64 Mn |
| Sep 30, 2025 | 6.62 Mn |
| Jun 30, 2025 | 6.60 Mn |
| Mar 31, 2025 | 6.64 Mn |
| Dec 31, 2024 | 6.36 Mn |
| Sep 30, 2024 | 6.72 Mn |
| Jun 30, 2024 | 6.57 Mn |
| Mar 31, 2024 | 6.42 Mn |
| Dec 31, 2023 | 6.27 Mn |
| Sep 30, 2023 | 6.11 Mn |
| Jun 30, 2023 | 5.94 Mn |
| Mar 31, 2023 | 5.76 Mn |
| Dec 31, 2022 | 5.57 Mn |
| Sep 30, 2022 | 5.37 Mn |
| Jun 30, 2022 | 5.17 Mn |
| Mar 31, 2022 | 5.18 Mn |
| Dec 31, 2021 | 5.03 Mn |
| Sep 30, 2021 | 4.90 Mn |